Busulcure (Busulfan Vials) 60mg

Busulcure (Busulfan) 60mg vials are an alkylating chemotherapy agent used in cancer treatment. This sterile injectable formulation is designed for intravenous use under medical supervision. Store between 2–8°C to maintain potency.

Strength

60mg

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Meone HealthCare Pvt Ltd.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Busulfan belongs to the class of alkylating agents and is primarily used in the treatment of certain cancers, including chronic myeloid leukemia and as part of conditioning regimens before stem cell or bone marrow transplants. It may also be used in palliative care for symptom management in select cases. Patients often ask what Busulfan 60mg is used for in oncology protocols.

Side Effects

Busulfan works by interfering with the growth of cancer cells, helping to reduce tumor size or slow disease progression. As a cytotoxic agent, it may cause temporary effects such as nausea or fatigue during therapy. Individual responses vary based on treatment duration and patient health.

Precautions & Warnings

Busulcure should be handled with care and administered by healthcare professionals in a controlled clinical setting. It requires proper storage at 2–8°C and should not be used if discolored or contains particles. Patients should report any signs of infection or unusual bleeding immediately.

Avoid Interactions

Busulfan may interact with other medications that affect liver enzymes, such as CYP inhibitors or inducers, potentially altering its effectiveness or toxicity. Combining it with nephrotoxic or hepatotoxic drugs may increase organ stress. Alcohol use should be avoided during treatment.

References

Frequently Asked Questions

Busulfan 60mg is primarily used in cancer treatment, including chronic myeloid leukemia and conditioning before stem cell transplants.

Store Busulcure vials between 2–8°C and protect from light. Do not freeze or expose to high temperatures.

Common effects may include nausea, fatigue, or lowered blood cell counts. Report any severe symptoms to your healthcare provider.

Busulfan may cause harm to unborn babies. Use effective contraception during and after treatment as advised by a doctor.

Busulcure can be purchased from licensed pharmacies or authorized online medical suppliers with a valid prescription.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.